Cytokinetics | Beneficio Operativo



Operating Profit Cambio Fecha
Acadia Pharmaceuticals USD 19.29M 134.21M 2025-03
Amgen USD 1.29B 1.02B 2025-03
Bayer EUR 3.53B 7.35B 2024-12
Biogen USD 311.2M 130.2M 2025-03
Bristol-Myers Squibb USD 3.41B 2.62B 2025-03
Cytokinetics USD -155631000 16.59M 2025-03
Eisai JPY 27.56B 13.14B 2024-12
Eli Lilly USD 5.41B 259.6M 2025-03
Exelixis USD 163.21M 27.13M 2025-01
Geron USD -16704000 5.05M 2025-03
Halozyme Therapeutics USD 141.54M 33.97M 2025-03
Ionis Pharmaceuticals USD -146000000 35.18M 2025-03
Ligand Pharmaceuticals USD -9637000 5.07B 2024-12
Merck USD 5.87B 1.57B 2025-03
Novartis USD 2.28B 1.34B 2024-12
Pfizer USD 3.67B 4.08B 2025-03
Regeneron Pharmaceuticals USD 591.7M 398.5M 2025-03
Roche Holding CHF 4.39B 1.04B 2024-12
Sanofi EUR 2.28B 1.42B 2025-03



Cytokinetics Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.